-
Amalia Enriquez-De-Salamanca
Ocular Surface Group, IOBA - University of Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
-
Antonio Abengózar-Vela
Ocular Surface Group, IOBA - University of Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
-
Carmen García-Vázquez
Ocular Surface Group, IOBA - University of Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
-
Chris S Schaumburg
Biological Sciences, Allergan Inc., Irvine, CA
-
Michael E Stern
Biological Sciences, Allergan Inc., Irvine, CA
-
Virginia L Calder
Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, United Kingdom
-
Margarita Calonge
Ocular Surface Group, IOBA - University of Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
-
Maria-Jesus J. Gonzalez
Ocular Surface Group, IOBA - University of Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain